AN2 Therapeutics Inc. (ANTX)
NASDAQ: ANTX
· Real-Time Price · USD
1.10
0.05 (4.27%)
At close: Aug 15, 2025, 3:59 PM
1.07
-2.73%
After-hours: Aug 15, 2025, 04:04 PM EDT
AN2 Therapeutics Fail-to-Deliver
Total FTD Shares
310
Below Average
FTD / Avg. Volume
0.16%
Low Impact
1-Year Change
-85.7%
Negative Trend
FTD Chart
As of Jun 9, 2025,
AN2 Therapeutics Inc. has
310
shares failed to deliver, representing 0.16%
of the average daily volume of
196,722
shares. Over the past year, the monthly average FTD is
61,377
shares, with the current level 99% below
the historical average, indicating
low
settlement pressure. The weighted FTD ratio below 1% suggests normal market making activity with adequate liquidity.
FTD History
| Date | Price | FTD Shares | % Change |
|---|---|---|---|
| Jun 09, 2025 | 1.12 | 310 | +154.10% |
| Apr 25, 2025 | 1.25 | 122 | +269.70% |
| Mar 21, 2025 | 1.46 | 33 | -99.10% |
| Dec 27, 2024 | 1.44 | 3.66K | -94.22% |
| Nov 19, 2024 | 1.06 | 63.42K | +660.60% |
| Oct 18, 2024 | 1.05 | 8.34K | -44.23% |
| Sep 26, 2024 | 1.06 | 14.95K | -92.88% |
| Aug 26, 2024 | 1.14 | 209.99K | +155446.67% |
| Jul 31, 2024 | 2.55 | 135 | -95.58% |
| Jun 28, 2024 | 2.15 | 3.06K | +6693.33% |
| May 30, 2024 | 2.04 | 45 | -99.26% |
| Apr 30, 2024 | 2.4 | 6.08K | +183.40% |
| Mar 26, 2024 | 3.12 | 2.15K | -27.83% |
| Feb 29, 2024 | 2.98 | 2.97K | +8155.56% |
| Jan 30, 2024 | 19.43 | 36 | -97.28% |
| Dec 28, 2023 | 20.9 | 1.32K | +2400.00% |
| Nov 29, 2023 | 16.33 | 53 | -93.13% |
| Oct 31, 2023 | 14.42 | 771 | -77.09% |
| Sep 29, 2023 | 16.08 | 3.37K | +65.11% |
| Aug 14, 2023 | 8.44 | 2.04K | +44.54% |
| Jul 25, 2023 | 8.02 | 1.41K | +1466.67% |
| Jun 30, 2023 | 8.5 | 90 | +260.00% |
| May 31, 2023 | 5.61 | 25 | -94.79% |
| Apr 26, 2023 | 8.18 | 480 | +74.55% |
| Mar 31, 2023 | 9.87 | 275 | -64.52% |
| Feb 28, 2023 | 11.28 | 775 | -48.40% |
| Jan 31, 2023 | 12.16 | 1.5K | n/a |